Most of the Hong Kong stocks in the innovative drug sector fell, with Jingtai Holdings (02228.HK) falling more than 4%, Ascent Pharmaceuticals (06855.HK) falling more than 3%, and WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) following suit.